Castleark Management LLC Takes $5.56 Million Position in Astera Labs, Inc. $ALAB

Castleark Management LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 61,530 shares of the company’s stock, valued at approximately $5,564,000.

A number of other hedge funds have also modified their holdings of ALAB. Alliancebernstein L.P. boosted its position in Astera Labs by 114.2% during the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after acquiring an additional 4,478,741 shares during the last quarter. Atreides Management LP lifted its position in shares of Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after purchasing an additional 2,815,614 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Astera Labs by 29.6% during the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares during the last quarter. FengHe Fund Management Pte. Ltd. bought a new position in Astera Labs in the second quarter valued at $106,772,000. Finally, 1832 Asset Management L.P. increased its stake in Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after buying an additional 929,600 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ALAB. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, September 2nd. Wall Street Zen cut Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Northland Securities upped their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Finally, Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Monday, November 17th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $188.17.

Astera Labs Trading Down 14.3%

Shares of NASDAQ ALAB opened at $148.85 on Monday. The company has a market capitalization of $25.14 billion, a P/E ratio of 134.10, a P/E/G ratio of 2.77 and a beta of 1.52. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a 50 day moving average of $166.62 and a 200-day moving average of $154.01.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same quarter last year, the firm posted $0.23 EPS. The company’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the completion of the sale, the chief financial officer directly owned 192,297 shares in the company, valued at $27,823,452.93. This trade represents a 5.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 586,936 shares of company stock worth $89,331,140 in the last ninety days. Insiders own 12.50% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.